Please assess the completion status of the following clinical trial:

Trial Title: Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Comatose with Blantyre Comas Score ≤ 3~* P. falciparum parasitemia~* Active seizure~Exclusion Criteria:~* Serum creatinine \> 2mg/dL~* Pre-admission/concomitant treatment with antiretroviral medications for HIV (ARVs), antituberculous treatments(ATTs), or chronic use of any other enzyme-inducing medications

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 6 Years
- Healthy Volunteers: f

Study Arms:
- LEVETIRACETAM (Type: OTHER): Open label, dose escalation to optimal dose.

Based on this trial design, predict the completion outcome and termination type (if applicable).